Dual Immunotherapy and Liver Perfusion Delays Progression in Uveal Melanoma
(MedPage Today) -- Adding the dual checkpoint inhibitor regimen of ipilimumab (Yervoy) and nivolumab (Opdivo) to percutaneous hepatic perfusion significantly ...
(MedPage Today) -- Adding the dual checkpoint inhibitor regimen of ipilimumab (Yervoy) and nivolumab (Opdivo) to percutaneous hepatic perfusion significantly ...
(MedPage Today) -- First-line treatment of advanced acral melanoma with the PD-1 inhibitor toripalimab (Loqtorzi) resulted in a small but ...
© 2025 PickByDoc. All rights reserved. PickByDoc is a medical news & health awareness platform.